BioGeometry secures Pre-A financing for generative AI in biomanufacturing
Jiangmen Ventures leads the 2024 round, joined by Zhipu AI, SJ Jiacheng and returning backer Gaorong.
BioGeometry completed a Pre-A financing disclosed on June 19, 2024. Jiangmen Ventures led the round, with Zhipu AI and SJ Jiacheng participating and Gaorong Capital investing again. The amount was not disclosed.
The financing came as the company launched GeoFlow for protein structure prediction and design. Its GeoBiologics platform had secured licensing partnerships with pharmaceutical companies, while collaborations with technology and biotechnology partners supported broader applications in biomanufacturing.
BioGeometry said it had built both computational protein-design and high-throughput experimental-validation platforms. That combination supported work across antibodies, peptides, vaccines and enzymes.
Use of funds
Accelerate generative AI applications in biomanufacturing
Develop proprietary biological products